Latest Coronavirus news
BNT162b2 Vaccine Effectiveness 92 Percent for Teens Ages 12 to 17
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adverse Events Rare After BNT162b2 Vaccine in 5- to 11-Year-Olds
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Vaccinated Kidney Transplant Recipients Vulnerable to SARS-CoV-2 Variants
posted December 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria .jpeg)
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI 
Early Complications Common in Older Kidney Transplant Recipients 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity Monthly Specialist Briefings
Stay Connected
